OurEnergyPolicy facilitates dialogue on energy policy issues and provides resources for American people, policymakers, and the media, self-described as non-partisan.

OurEnergyPolicy

Renew Financial is a leading provider of residential Property Assessed Clean Energy (R-PACE) financing, pioneering innovative, low-cost financing solutions for energy-efficiency, water conservation, and resiliency improvements.

Cisco DeVries

Renew Financial

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Repligen Corporation

Terra-Gen is a leading integrated and independent renewable energy power producer in the United States, committed to providing affordable, clean energy at a large scale to help achieve energy security, grid resiliency, and combat climate change.

Metric
Company Name	OurEnergyPolicy	Renew Financial	Repligen Corporation	Terra-Gen
Symbol			RGEN
MSH ID	ORG:OURENERGYPOLICY	COM:RENEWFINANCIAL	COM:REPLIGEN	COM:TERRA-GEN
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Public & Social Sector	Clean Energy Financing	Healthcare	Energy
Industry	Energy	Financial Services	Medical - Instruments & Supplies	Renewable Energy
Country	US	US	US
Stage
Employee Count		185	1.78K	101
Website	ourenergypolicy.org	renewfinancial.com	repligen.com	terra-gen.com
LinkedIn		renewable-funding-llc
Founders

Metric
Market Cap			6.76B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue			638.76M
Revenue (LTM)
Revenue (NTM)
Gross Profit			284.25M
EBITDA			131.39M
Operating Income			63.31M
Net Income			41.58M
EPS			0.75
Diluted EPS			0.74
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.55
Operating Profit Margin			0.09
EBITDA Margin			0.21
Net Profit Margin			0.07
Return on Equity			0.05
Return on Assets			0.01
Return on Capital Employed			0.02

ORG:OURENERGYPOLICY

OurEnergyPolicy

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			94.12
P/B Ratio			23.47
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			17.43
EV Multiple			1.27K

Metric
Days Sales Outstanding			57.85
Days Payables Outstanding			19.41
Days Inventory Outstanding			258.37
Operating Cycle			333.05
Cash Conversion Cycle			304.69
Asset Turnover			0.23

Metric
Operating Cash Flow			113.92M
Free Cash Flow			74.93M
Cash Flow to Debt			0.26
Operating Cash Flow/Sales			0.26
Free Cash Flow Yield			0.01

Metric
Cash & Equivalents			751.32M
Accounts Receivable			-3.31M
Inventory			202.32M
Goodwill			987.12M
Debt to Capitalization			0.27
Debt to Assets			0.17
Current Ratio			2.69
Quick Ratio			13.45

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.04
R&D to Revenue			0.07
SG&A to Revenue